These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11579829)

  • 1. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
    Bronisz M; Rość D; Paczuski R; Nartowicz E; Bronisz A
    Pol Merkur Lekarski; 2001 Jul; 11(61):40-3. PubMed ID: 11579829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
    Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A
    Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.
    Holvoet P; Donck J; Landeloos M; Brouwers E; Luijtens K; Arnout J; Lesaffre E; Vanrenterghem Y; Collen D
    Thromb Haemost; 1996 Nov; 76(5):663-9. PubMed ID: 8950769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor binding to collagen in patients with end-stage renal disease.
    Niesvizky R; Calandri C; Patel ND; Zhou SL; Potter BJ; Rand JH
    J Lab Clin Med; 1994 Jan; 123(1):137-42. PubMed ID: 8288954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Von Willebrand factor in plasma of patients with age related macular degeneration].
    Malukiewicz-Wiśniewska G; Rość D; Kałuzny B; Kałuzny JJ
    Klin Oczna; 2005; 107(1-3):70-2. PubMed ID: 16052806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of severe multiple trauma complicated by acute lung injury on endothelial cell activity].
    Siemiatkowski A; Kłoczko J; Wereszczyńska-Siemiatkowska U; Czaban SL
    Przegl Lek; 2001; 58(7-8):767-71. PubMed ID: 11769384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor (vWF) antigen levels and function in healthy Thais.
    Rojnuckarin P; Akkawat B; Intragumtornchai T
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1292-7. PubMed ID: 16438160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
    Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunction.
    Villa P; Iborra J; Serra J; Gilsanz A; Casaña P; Aznar JA; Aznar J
    Haematologica; 2001 Nov; 86(11):1180-5. PubMed ID: 11694404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
    Borawski J; Naumnik B; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Markers of endothelial stimulation in hyperthyroidism].
    Rość D; Drewniak W; Zastawna E; Paczuski R; Graczykowska-Koczorowska A
    Pol Merkur Lekarski; 1999 Feb; 6(32):79-81. PubMed ID: 10337177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of ozone therapy on endothelial damage markers in patients with atherosclerosis of lower extremities].
    Rość D; Ponikowska I; Paczuski R; Włodarczyk K; Zastawna E; Michalski A
    Pol Merkur Lekarski; 1999 Mar; 6(33):135-7. PubMed ID: 10365597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Von Willebrand factor in plasma of patients with rheumatoid arthritis and lupus erythematosus].
    Paczuski R; Iwan-Zietek I; Kotschy M; Bielawska J; Sadkiewicz S
    Pol Merkur Lekarski; 1998 May; 4(23):254-6. PubMed ID: 9825655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content and functional activity of von Willebrand factor in apheresis plasma.
    Burnouf T; Caron C; Burkhardt T; Goudemand J
    Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
    Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
    Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.